Ozempic is a once-weekly subcutaneous injection (0.5, 1, or 2 mg) approved for type 2 diabetes glycemic control, cardiovascular risk reduction, and kidney disease protection in T2D patients with CKD
Although our data suggest that LDHB suppresses ferroptosis via the production of mitochondrial CoQH2, we cannot exclude the possibility of other potential mechanisms, as recently also discussed for GPD2 20
As we age, collagen production naturally declines, which contributes to wrinkles, sagging skin, and joint discomfort
The study found that D-allulose caused a significant release of CCK, GLP-1, and PYY compared with the control
If I taped your mouth shut, youd lose weight, but youd be more hungry. Still, when people on GLP-1s reach a new weight plateauusually within monthsthey often start to feel hungry again
Additional strategies to minimise gastrointestinal side effects include: Eating smaller, more frequent meals rather than large portions Avoiding high-fat, greasy, or spicy foods , which can exacerbate nausea Staying well-hydrated , particularly if experiencing vomiting or diarrhoea Eating slowly and stopping when comfortably satisfied, as Ozempic slows gastric emptying Remaining upright for 3060 minutes after meals to aid digestion Important safety considerations: Monitor for hypoglycaemia if taking Ozempic with insulin or sulfonylureas Be aware of gallbladder disease symptoms (right upper abdominal pain, fever, jaundice) Report any new or worsening visual symptoms promptly, as rapid improvement in blood glucose can worsen diabetic retinopathy in some patients If side effects are severe or persistent, contact your GP or diabetes specialist
